Company / Depreciation & Amortization
Lexaria Bioscience Corp. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$42.4K
FY2025
5-year range
$42.4K / $145.4K
FY2021-FY2025
Trend
-70.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 9 years, ranging from $0 in FY2016 to $145,397 in FY2024.
Based on SEC 10-K filings.
$42,448 in FY2025 with a 5-year CAGR of -6.9%.
Improved from $102,718 to $42,448 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -27.6%
- 5-Year CAGR
- -6.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -6.9%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 70.8% year-over-year.
- Peak depreciation & amortization was recorded in FY2024.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $42.4K | -70.8% |
| FY2024 | $145.4K | +41.5% |
| FY2023 | $102.7K | -8.1% |
| FY2022 | $111.7K | -0.9% |
| FY2021 | $112.8K | +86.2% |
| FY2020 | $60.5K | +2524.6% |
| FY2019 | $2.3K | +272.7% |
| FY2017 | $619 | - |
| FY2016 | $0 | - |
| FY2015 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026